treatment of tumorigenic cells because of its intrinsic advantages such as precise spatiotemporal selectivity and high specificity. [1] PTT involves the utilization of near-infrared (NIR) photoabsorbing agents to convert external NIR laser energy into local thermal energy to induce hyperthermia effect and thermal ablation of tumorigenic cells. [2] Unfortunately, tumor cells treated with hyperthermia have been demonstrated to induce thermoresistance, which substantially improves their survival capability, thus causing unsatisfactory treatment outcomes in PTT. [3] The heat-shock proteins (HSPs) have been extensively perceived as crucial factors in capacitating tumor cells to resist hyperthermia-induced cell death and initiate the defense mechanism of tumors. [4] To increase the susceptibility of tumor cells to hyperthermia effects, small-interfering RNA and specific HSP inhibitors have been utilized in hyperthermia-effectinvolved tumor treatment. [5] However, an obvious hysteretic effect appears upon the utilization of small molecular inhibitors because they can influence the existing HSPs after thermal stimulation rather than before the treatment process. In addition, these inhibitors lack generalizability as one specific inhibitor only targets one type of HSPs, thereby severely hindering their inhibition efficacy against the HSPs. [6] Hence, there is an imperative demand Photothermal therapy (PTT) has emerged as a distinct therapeutic modality owing to its noninvasiveness and spatiotemporal selectivity. However, heat-shock proteins (HSPs) endow tumor cells with resistance to heatinduced apoptosis, severely lowering the therapeutic efficacy of PTT. Here, a high-performance pyroelectric nanocatalyst, Bi 13 S 18 I 2 nanorods (NRs), with prominent pyroelectric conversion and photothermal conversion performance for augmented pyrocatalytic tumor nanotherapy, is developed. Canonical binary compounds are reconstructed by inserting a third biocompatible agent, thus facilitating the formation of Bi 13 S 18 I 2 NRs with enhanced pyrocatalytic conversion efficiency. Under 808 nm laser irradiation, Bi 13 S 18 I 2 NRs induce a conspicuous temperature elevation for photonic hyperthermia. In particular, Bi 13 S 18 I 2 NRs harvest pyrocatalytic energy from the heating and cooling alterations to produce abundant reactive oxygen species, which results in the depletion of HSPs and hence the reduction of thermoresistance of tumor cells, thereby significantly augmenting the therapeutic efficacy of photothermal tumor hyperthermia. By synergizing the pyroelectric dynamic therapy with PTT, tumor suppression with a significant tumor inhibition rate of 97.2% is achieved after intravenous administration of Bi 13 S 18 I 2 NRs and subsequent exposure to an 808 nm laser. This work opens an avenue for the design of high-performance pyroelectric nanocatalysts by reconstructing canonical binary compounds for therapeutic applications in biocatalytic nanomedicine.